Comorbid disease drives short-term hospitalization outcomes in patients with multiple sclerosis
Conclusions
Comorbid diseases were associated with the readmission for persons with multiple sclerosis. Evaluations of the real-world effectiveness for DMTs in reducing hospitalizations in patients with MS may need to consider comorbid disease burden and management.
Source: Neurology Clinical Practice - Category: Neurology Authors: Mendizabal, A., Thibault, D. P., Crispo, J. A., Paley, A., Willis, A. W. Tags: All Health Services Research, Outcome research, Multiple sclerosis, Cohort studies Source Type: research
More News: Anemia | Arthritis | Brain | Cardiology | Congestive Heart Failure | Databases & Libraries | Diabetes | Eating Disorders & Weight Management | Endocrinology | Heart | Heart Failure | Hypertension | Insurance | Medicare | Men | Multiple Sclerosis | Neurology | Obesity | Renal Failure | Rheumatoid Arthritis | Rheumatology | Study | Women